Magnetar Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Magnetar Financial’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,052,642	Closed	-$96.5M	–	1175
2025 Q2	$96.5M	Buy	+2,052,642	New	+$91.3M	0.47%	3
2024 Q3	–	Sell	-13,338	Closed	-$502K	–	685
2024 Q2	$502K	Buy	+13,338	New	+$561K	0.01%	330

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Magnetar Financial's SWTX Position: Q3 2025 in Review

Magnetar Financial sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 2,052,642 shares — an estimated $96.5M sold.

Magnetar Financial first reported a position in SWTX in Q2 2024 and held it in 2 quarters. The position peaked at $96.5M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Magnetar Financial reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Magnetar Financial sold 2,052,642 SpringWorks Therapeutics shares in Q3 2025, an estimated $96.5M.
Magnetar Financial first reported a position in SpringWorks Therapeutics in Q2 2024 and held it in 2 quarters.
Magnetar Financial's SpringWorks Therapeutics position peaked at $96.5M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.